• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何识别和治疗小肠细菌过度生长?

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?

作者信息

Skrzydło-Radomańska Barbara, Cukrowska Bożena

机构信息

Department of Gastroenterology, Medical University of Lublin, Jaczewskiego 8, 20-950 Lublin, Poland.

Department of Pathomorphology, The Children Memorial Health Institute, Aleja Dzieci Polskich 20, 04-730 Warsaw, Poland.

出版信息

J Clin Med. 2022 Oct 12;11(20):6017. doi: 10.3390/jcm11206017.

DOI:10.3390/jcm11206017
PMID:36294338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9604644/
Abstract

Small Intestinal Bacterial Overgrowth (SIBO) is a form of dysbiosis that involves increased bacterial colonization of the small intestine with some of the bacteria more characteristic of the colon microbiota. The prevalence of SIBO over recent decades has been estimated to range from 2.5 to 22% (depending on the source) and to increase with age and among individuals with comorbidities. Recently, an increase in the number of diagnosed SIBO cases has been observed, which is primarily due to the availability of noninvasive breath tests that facilitate the diagnostic process. However, SIBO is still both a diagnostic and a therapeutic problem. This review presents the pathophysiology, manifestations, diagnostics, and recommended management of SIBO.

摘要

小肠细菌过度生长(SIBO)是一种生态失调形式,涉及小肠细菌定植增加,其中一些细菌更具结肠微生物群的特征。近几十年来,SIBO的患病率估计在2.5%至22%之间(取决于来源),并随年龄增长以及在患有合并症的个体中增加。最近,已观察到确诊的SIBO病例数量有所增加,这主要归因于非侵入性呼气试验的应用,这些试验有助于诊断过程。然而,SIBO仍然是一个诊断和治疗难题。本综述介绍了SIBO的病理生理学、表现、诊断及推荐的管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c13/9604644/a459ccd593ce/jcm-11-06017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c13/9604644/a459ccd593ce/jcm-11-06017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c13/9604644/a459ccd593ce/jcm-11-06017-g001.jpg

相似文献

1
How to Recognize and Treat Small Intestinal Bacterial Overgrowth?如何识别和治疗小肠细菌过度生长?
J Clin Med. 2022 Oct 12;11(20):6017. doi: 10.3390/jcm11206017.
2
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.肠道菌群失调和小肠细菌过度生长作为肝硬化中肠道微生物群紊乱的独立形式。
World J Gastroenterol. 2022 Mar 14;28(10):1067-1077. doi: 10.3748/wjg.v28.i10.1067.
3
[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].小肠细菌过度生长型肠易激综合征的临床特征及利福昔明疗效的初步研究
Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005.
4
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.小肠细菌过度生长与肠易激综合征:功能性与器质性二分法之间的桥梁
Gut Liver. 2017 Mar 15;11(2):196-208. doi: 10.5009/gnl16126.
5
Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征中小肠细菌过度生长相关的十二指肠和直肠黏膜微生物群。
J Gastroenterol Hepatol. 2020 May;35(5):795-805. doi: 10.1111/jgh.14910. Epub 2019 Nov 5.
6
Diagnosis and treatment of small intestinal bacterial overgrowth.小肠细菌过度生长的诊断与治疗
Expert Rev Gastroenterol Hepatol. 2016;10(2):215-27. doi: 10.1586/17474124.2016.1110017. Epub 2015 Dec 4.
7
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).小檗碱和利福昔明对小肠细菌过度生长的影响:一项研究者发起的双臂、开放标签、随机临床试验的研究方案(BRIEF-SIBO研究)
Front Pharmacol. 2023 Feb 15;14:1121435. doi: 10.3389/fphar.2023.1121435. eCollection 2023.
8
Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.肠易激综合征饮食治疗小肠细菌过度生长的疗效:叙述性综述。
Nutrients. 2022 Aug 17;14(16):3382. doi: 10.3390/nu14163382.
9
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.临床试验:利福昔明联合部分水解瓜尔胶在根除小肠细菌过度生长方面比利福昔明单独使用更有效。
Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18.
10
Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.利福昔明在治疗产氢的小肠细菌过度生长中的优先应用。
Rev Gastroenterol Peru. 2019 Apr-Jun;39(2):111-115.

引用本文的文献

1
Clinical utility of small intestinal bacterial overgrowth (SIBO) testing in guiding management of gas-bloat symptoms after antireflux surgery.小肠细菌过度生长(SIBO)检测在指导抗反流手术后气胀症状管理中的临床效用。
Surg Endosc. 2025 Aug 28. doi: 10.1007/s00464-025-12092-7.
2
Incidence and Characterization of SIBO in NAFLD Patients.非酒精性脂肪性肝病患者小肠细菌过度生长的发生率及特征
Euroasian J Hepatogastroenterol. 2025 Jan-Jun;15(1):38-43. doi: 10.5005/jp-journals-10018-1468. Epub 2025 Jun 18.
3
The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis.利福昔明治疗小肠细菌过度生长的疗效:系统评价和荟萃分析。
Expert Rev Gastroenterol Hepatol. 2021 Dec;15(12):1385-1399. doi: 10.1080/17474124.2021.2005579. Epub 2021 Nov 26.
2
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.低 FODMAP 饮食对肠易激综合征的疗效:系统评价和网络荟萃分析。
Gut. 2022 Jun;71(6):1117-1126. doi: 10.1136/gutjnl-2021-325214. Epub 2021 Aug 10.
3
Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
质子泵抑制剂治疗的持续时间与小肠细菌过度生长风险:一项系统评价和荟萃分析。
J Clin Med. 2025 Jul 3;14(13):4702. doi: 10.3390/jcm14134702.
4
Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review.小肠细菌过度生长的营养治疗方法:一项叙述性综述
Nutrients. 2025 Apr 23;17(9):1410. doi: 10.3390/nu17091410.
5
Small intestinal bacterial overgrowth and intestinal methanogen overgrowth in gastrointestinal malignancies.胃肠道恶性肿瘤中的小肠细菌过度生长和肠道产甲烷菌过度生长
Contemp Oncol (Pozn). 2025;29(1):11-21. doi: 10.5114/wo.2025.148643. Epub 2025 Mar 18.
6
Small intestinal bacterial overgrowth in variant transthyretin amyloidosis (A-ATTRv).变异型转甲状腺素蛋白淀粉样变性(A-ATTRv)中的小肠细菌过度生长
Orphanet J Rare Dis. 2025 May 2;20(1):210. doi: 10.1186/s13023-025-03727-y.
7
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives.小肠细菌和真菌过度生长:对健康的影响及管理策略
Nutrients. 2025 Apr 17;17(8):1365. doi: 10.3390/nu17081365.
8
A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth.一项评估利福霉素SV MMX两种给药方案治疗小肠细菌过度生长疗效的随机开放标签试验性研究。
BMC Gastroenterol. 2025 Apr 3;25(1):219. doi: 10.1186/s12876-025-03804-3.
9
DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.小肠细菌过度生长的诊断与治疗:巴西胃肠病学联合会官方立场文件
Arq Gastroenterol. 2025 Feb 17;62:e24107. doi: 10.1590/S0004-2803.24612024-107. eCollection 2025.
10
A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth.益生元、益生菌和后生元在小肠细菌过度生长诊断与治疗中应用价值的全面综述
Microorganisms. 2025 Jan 1;13(1):57. doi: 10.3390/microorganisms13010057.
炎症性肠病和肠易激综合征中小肠细菌过度生长与甲烷阳性的关系:系统评价和荟萃分析。
Gut Microbes. 2021 Jan-Dec;13(1):1933313. doi: 10.1080/19490976.2021.1933313.
4
Every Breath Test You Take: Practical Advice on Breath Testing Used to Detect Small Intestinal Bacterial Overgrowth.你所做的每次呼气测试:关于用于检测小肠细菌过度生长的呼气测试的实用建议。
Dig Dis Sci. 2021 Feb;66(2):331-333. doi: 10.1007/s10620-020-06776-4. Epub 2021 Jan 11.
5
Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing.小肠细菌过度生长综合征:呼气检测的合理应用指南。
Dig Dis Sci. 2021 Feb;66(2):338-347. doi: 10.1007/s10620-020-06623-6. Epub 2020 Oct 10.
6
Effects of Probiotics Supplementation on Gastrointestinal Symptoms and SIBO after Roux-en-Y Gastric Bypass: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.益生菌补充对 Roux-en-Y 胃旁路术后胃肠道症状和小肠细菌过度生长的影响:一项前瞻性、随机、双盲、安慰剂对照试验。
Obes Surg. 2021 Jan;31(1):143-150. doi: 10.1007/s11695-020-04900-x. Epub 2020 Aug 11.
7
Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods.小肠细菌过度生长:诊断、预防及治疗方法的全面综述
Cureus. 2020 Jun 27;12(6):e8860. doi: 10.7759/cureus.8860.
8
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update.小肠细菌过度生长与肠易激综合征——最新进展
Front Psychiatry. 2020 Jul 10;11:664. doi: 10.3389/fpsyt.2020.00664. eCollection 2020.
9
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.AGA 临床实践更新:小肠细菌过度生长:专家评论。
Gastroenterology. 2020 Oct;159(4):1526-1532. doi: 10.1053/j.gastro.2020.06.090. Epub 2020 Jul 15.
10
ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.ACG 临床指南:小肠细菌过度生长。
Am J Gastroenterol. 2020 Feb;115(2):165-178. doi: 10.14309/ajg.0000000000000501.